Experience:
No experience
Employment Type:
Intern/Co-op
Posted:
8/14/2019
Job Category:
Business Development
See more jobs for students and recent grads who studied:
Intern- Process Development
alkermes | waltham, Massachusetts
Tell Us More About Your Job Preferences
By telling us what you think of this job, we can help find jobs that match your interests. If you want to see more jobs like this, click on the smiley face. Or if this job isn't what you are looking for, click the frowny face. Learn More...

Follow This Company
Share

Job Description

Company Overview

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com .

Spring 2020 Intern Position Summary

Alkermes is seeking a talented individual to intern in our Process Development Department in Waltham, MA. As an intern, the selected candidate will support the ongoing work on characterizing the mechanical properties of granular pharmaceutical materials that are paramount to the success of solid dosage forms manufacturing. Specifically, the project focuses on developing critical state constitutive models for quantifying the flow and compression of pharmaceutical excipients. The candidate should have in depth knowledge of solid mechanics and the current state-of-the art in this field. The program offers the candidate with hands-on experience in various solid-state characterization techniques, and the opportunity to gain fundamental understanding of key aspects of pharmaceutical manufacturing processes.

Preferred Education and Experience

Currently enrolled in an undergraduate/graduate program in Mechanical Engineering, Chemical Engineering, Bio-Medical Engineering or related discipline.

Minimum GPA 3.2

Preferred Advanced Competencies

* Background in solid mechanics


* Experience with granular material processes


* Proficiency with electronic notebook


* Proficiency in Python, MATLAB


* Highly motivated and detail oriented


* Ability to apply scientific principles to design, execute and interpret experiments


* Team player with good interpersonal skills


* Excellent written and oral communication



Personal Attributes Needed

* Motivated self-starter


* Positive, adaptable, can-do attitude


* Ability to work independently


* Ability to travel and work flexible hours as required


* Functional ability to work in a pilot plant and commercial facility



Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law.

About alkermes

Alkermes, Inc. (Alkermes) is an integrated biotechnology company. The Company has developed, manufactured and commercialized VIVITROL for alcohol dependence and manufactured RISPERDAL CONSTA for schizophrenia and bipolar disorder. Its pipeline includes injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. It has research facilities in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is the long-acting, atypical antipsychotic to be approved by the United States Food and Drug Administration (FDA). RISPERDAL CONSTA is approved for the treatment of schizophrenia in approximately 85 countries and marketed in approximately 60 countries. In the United States, RISPERDAL CONSTA is also approved for the treatment of bipolar I disorder. (Source: 10-K)

This company profile was created by AfterCollege and is about alkermes. This page is not endorsed by or affiliated with alkermes. For questions regarding company profiles, please email: care@aftercollege.com.